Industry experts say biotechs must prioritize validation, maturity, and alternative financing to overcome a lack of long-term funding.
Funding lifelines: How to cross the 'valley of death'
Related Posts
UEF’s Rs 50 cr venture fund set to power start-ups in TN
CHENNAI: The three-day UEF Trade Summit 2025 concluded on Sunday at the Chennai Trade Centre, marking a significant milestone with the signing of a series […]
2025 Holiday Spending Rose 4%, Fueled by Ecommerce Sales Growth Topping 7%
While the final numbers on holiday 2025 are still being compiled, it appears that the season was a strong one, with both Visa and Mastercard […]
Pentathlon Ventures announces final close of ₹255-Cr Fund II to back early-stage startups | Business Review Live | Business News, Reviews | Entrepreneur Stories, Interviews | Kerala
Pentathlon Ventures, an early-stage venture capital firm specializing in B2B technology, announced the final close of its second fund at Rs 255 Crores today. The […]